Research Appraisalother

Advancements in artificial intelligence for atopic dermatitis: diagnosis, treatment, and patient management

Ann MedCao, Fang, Yang, Yujie, Guo, Cui et al.1 Dec 2025DOI

Clinical Snapshot

20CEBM
Evidence: Weakother

PICO Framework

P — PopulationPatients with atopic dermatitis
I — InterventionArtificial intelligence applications (deep learning algorithms, image recognition systems)
C — ComparatorTraditional diagnostic and treatment methods
O — OutcomesDiagnostic accuracy, treatment monitoring, patient care outcomes, quality of life

Bottom Line

This narrative review explores artificial intelligence applications in atopic dermatitis care, highlighting potential benefits in diagnosis, treatment monitoring, and patient management. While the authors identify promising applications of deep learning for skin image recognition and personalised treatment planning, the review lacks the systematic methodology required for evidence-based recommendations. The absence of quantitative results, quality assessment, and critical evaluation limits its clinical utility. The acknowledged challenges around data privacy and model transparency reflect real-world implementation barriers. Australian clinicians should await more rigorous systematic reviews and regulatory approval before considering AI tools for routine AD management. Current evidence is insufficient to support practice change, though the field shows promise for future development.

Evidence: Weak

Key Findings

  • Effect Size: Not quantified

  • Primary Outcome: AI applications show promise in AD diagnosis and management

  • Nnt Or Sensitivity: Deep learning algorithms demonstrate 'strong performance' in skin image recognition (specific metrics not provided)

  • Confidence Interval: Not provided

Clinical Application

Limited by current challenges in data privacy, model transparency, and regulatory approval TGA approval would be required for AI diagnostic tools; integration with existing dermatology services and telehealth platforms could enhance access in rural areas Patients with atopic dermatitis across all age groups

Abstract

Atopic dermatitis (AD) is a common and complex skin disease that significantly affects the quality of life of patients. The latest advances in artificial intelligence (AI) technology have introduced new methods for diagnosing, treating, and managing AD. AI has various innovative applications in the diagnosis and treatment of atopic dermatitis, with particular emphasis on its significant benefits in medical diagnosis, treatment monitoring, and patient care. AI algorithms, especially those that use deep learning techniques, demonstrate strong performance in recognizing skin images and effectively distinguishing different types of skin lesions, including common AD manifestations. In addition, artificial intelligence has also shown promise in creating personalized treatment plans, simplifying drug development processes, and managing clinical trials. Despite challenges in data privacy and model transparency, the potential of artificial intelligence in advancing AD care is enormous, bringing the future to precision medicine and improving patient outcomes. This manuscript provides a comprehensive review of the application of AI in the process of AD disease for the first time, aiming to play a key role in the advancement of AI in skin health care and further enhance the clinical diagnosis and treatment of AD.

References

  1. 1.Cao, F., Yang, Y., Guo, C., Zhang, H., Yu, Q., & Guo, J. (2025). Advancements in artificial intelligence for atopic dermatitis: diagnosis, treatment, and patient management. Annals of Medicine. https://doi.org/10.3233/SHTI231103
Share:XLinkedIn

This content is for educational purposes for healthcare professionals only and does not constitute clinical advice. Clinical decisions should be based on individual patient assessment, current guidelines, and appropriate specialist consultation. Editorial Standards · Privacy Policy · Terms of Service